GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Drs. Stephen I. Rennard and Igor Barjaktarevic discuss the diverse clinical aspects of COPD, emphasizing the role of inflammation and the importance of recognizing the heterogeneity of COPD.

Stephen Rennard +1 more

Past event

14November2023

Learning objectives

Understand the heterogeneous clinical presentation of COPD (eg, severity, level of control, symptoms, multimorbidities)
Review the role of underlying inflammation in COPD pathology and its link to clinical features
Review the role of biomarker assessments and endotyping in COPD

Description

Join Drs. Stephen I. Rennard and Igor Barjaktarevic as they explore the heterogeneous clinical presentation of COPD, addressing variations in severity, symptoms, and comorbidities. Diving into the role of underlying inflammation in COPD pathology, they highlight its connection to clinical features while also discussing the evolving role of biomarker assessments and endotyping in enhancing our understanding of COPD.

Speakers

Pulmonology

Stephen Rennard

Professor in the Division of Pulmonary, Critical Care and Sleep Medicine Division | University of Nebraska Medical Center

Pulmonology

MD, PhD

Igor Barjaktarevic

Assistant Professor of Medicine, Medical Director of COPD Program | David Geffen School of Medicine at University of California-Los Angeles

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region

Pulmonology

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Drs. Stephen I. Rennard and Igor Barjaktarevic discuss the diverse clinical aspects of COPD, emphasizing the role of inflammation and the importance of recognizing the heterogeneity of COPD.

Stephen Rennard +1 more

Past event

14November2023

Learning objectives

Understand the heterogeneous clinical presentation of COPD (eg, severity, level of control, symptoms, multimorbidities)
Review the role of underlying inflammation in COPD pathology and its link to clinical features
Review the role of biomarker assessments and endotyping in COPD

Description

Speakers

Pulmonology

Stephen Rennard

Professor in the Division of Pulmonary, Critical Care and Sleep Medicine Division | University of Nebraska Medical Center

Pulmonology

MD, PhD

Igor Barjaktarevic

Assistant Professor of Medicine, Medical Director of COPD Program | David Geffen School of Medicine at University of California-Los Angeles